Case number: 8:24-bk-80040 - Eiger BioPharmaceuticals, Inc. - Texas Northern Bankruptcy Court

Case Information
  • Case title

    Eiger BioPharmaceuticals, Inc.

  • Court

    Texas Northern (txnbke)

  • Chapter

    11

  • Judge

    Stacey G Jernigan

  • Filed

    04/01/2024

  • Last Filing

    08/16/2025

  • Asset

    Yes

  • Vol

    v

Docket Header
SEALEDEXH, SealedDocument, REFORM, COMPLEX, jntadmn, LEAD, ClaimsAgent, EXHIBITS



U.S. Bankruptcy Court
Northern District of Texas (Mega Docket DAL)
Bankruptcy Petition #: 24-80040-sgj11

Assigned to: Chief Bankruptcy Jud Stacey G Jernigan
Chapter 11
Voluntary
Asset


Date filed:  04/01/2024
341 meeting:  05/13/2024

Debtor

Eiger BioPharmaceuticals, Inc.

c/o Douglas Staut, CRO
2100 Ross Avenue
Dallas, TX 75201
SANTA CLARA-CA
Tax ID / EIN: 33-0971591

represented by
Thomas Robert Califano

Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-5575
Fax : 212-839-5599
Email: tom.califano@sidley.com

Veronica A. Courtney

Sidley Austin LLP
1000 Louisiana Street
Ste 5900
Houston, TX 77002
713-495-4572
Fax : 713-495-7799
Email: vcourtney@sidley.com

William E Curtin

Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-6745
Fax : 212-839-5599
Email: wcurtin@sidley.com

John Joseph Kuster

Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-7336
Email: jkuster@sidley.com

Jonathan W. Muenz

Sidley Austin LLP
787 7th Avenue
New York, NY 10019
212-839-5901
Fax : 212-839-5599
Email: jmuenz@sidley.com

Patrick J. Neligan, Jr.

Neligan LLP
4851 LBJ Freeway
Suite 700
Dallas, TX 75244
214-912-9861
Email: pneligan@neliganlaw.com

Charles Martin Persons, Jr.

Paul Hastings LLP
2001 Ross Avenue
Suite 2700
Dallas, TX 75201
972-936-7500
Fax : 972-936-7501
Email: charlespersons@paulhastings.com
TERMINATED: 09/24/2024

Andrew J. Townsell

Sidley Austin LLP
787 7th Avenue
New York, NY 10019
212-839-6793
Email: andrew.townsell@sidley.com

Anne G. Wallice

Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-6021
Email: anne.wallice@sidley.com

U.S. Trustee

United States Trustee

1100 Commerce Street
Room 976
Dallas, TX 75202
214-767-8967

represented by
Elizabeth Ziegler Young

U.S. Trustee Office
1100 Commerce Street, Room 976
Dallas, TX 75242
(214) 767-8967
Fax : (214) 767-8971
Email: elizabeth.a.young@usdoj.gov

Creditor Committee

Official Unsecured Creditors Committee

Munsch Hardt Kopf & Harr, P.C.
500 N. Akard Street
Suite 4000
Dallas, TX 75201
214-855-7500
represented by
Shira A. Baratz

Meland Budwick, P.A.
200 S. Biscayne Blvd., Suite 3200
MIami, FL 33131
305-358-6363
Fax : 305-358-1221
Email: sbarttz@melandbudwick.com

Thomas Daniel Berghman

Munsch Hardt Kopf & Harr PC
500 N Akard Street, Suite 3800
Dallas, TX 75201-6659
(214) 855-7554
Fax : (214) 978-4346
Email: tberghman@munsch.com

Michael S. Budwick

Meland Budwick, P.A.
200 S. Biscayne Blvd., Suite 3200
MIami, FL 33131
305-358-6363
Fax : 305-358-1221
Email: mbudwick@melandbudwick.com

Daniel N. Gonzalez

Meland Budwick, PA
200 S. Biscayne Boulevard, Suite 3200
Miami, FL 33131
(305) 358-6363
Fax : (305) 358-1221
Email: dgonzalez@melandbudwick.com

Meaghan E. Murphy

Meland Budwick, P.A.
200 S. Biscayne Blvd., Suite 3200
MIami, FL 33131
305-358-6363
Fax : 305-358-1221
Email: mmurphy@melandbudwick.com

Garrick Chase Smith

Munsch Hardt Kopf & Harr, P.C.
500 N. Akard Street
Suite 4000
Dallas, TX 75201
214-740-5110
Fax : 214-855-7584
Email: gsmith@munsch.com

Latest Dockets

Date Filed#Docket Text
08/16/2025902Chapter 11 Post-Confirmation Report for the Quarter Ending: 06/30/2025 filed by Jointly Administered Party/Debtor EigerBio Europe Limited. (Califano, Thomas)
08/16/2025901Chapter 11 Post-Confirmation Report for the Quarter Ending: 06/30/2025 filed by Debtor Eiger BioPharmaceuticals, Inc.. (Califano, Thomas)
08/16/2025900Chapter 11 Post-Confirmation Report for the Quarter Ending: 06/30/2025 filed by Jointly Administered Party/Debtor EBPI Merger Inc.. (Califano, Thomas)
08/16/2025899Chapter 11 Post-Confirmation Report for the Quarter Ending: 06/30/2025 filed by Jointly Administered Party/Debtor EB Pharma LLC. (Califano, Thomas)
08/16/2025898Chapter 11 Post-Confirmation Report for the Quarter Ending: 06/30/2025 filed by Jointly Administered Party/Debtor Eiger BioPharmaceuticals Europe Limited. (Califano, Thomas)
08/12/2025897Chapter 11 Post-Confirmation Report for the Quarter Ending: 06/30/2025 for Liquidating Trust for Eiger BioPharmaceuticals, Inc. filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee. (Venus, S.)
08/11/2025896Withdrawal of Liquidating Trustee's and Plan Administrator's Objection to Claim Nos. 83 and 43 Filed by Merck Sharp and Dohme LLC filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[771] Objection to claim). (Venus, S.)
08/06/2025895BNC certificate of mailing - PDF document. (RE: related document(s)[894] Order granting Progeria Research Foundation's motion to file response under seal (related document [819]) Entered on 8/4/2025.) No. of Notices: 2. Notice Date 08/06/2025. (Admin.)
08/04/2025894Order granting Progeria Research Foundation's motion to file response under seal (related document # [819]) Entered on 8/4/2025. (Grandstaff, Travis)
08/03/2025893BNC certificate of mailing. (RE: related document(s)[892] Clerk's correspondence requesting an order from attorney for creditor. (RE: related document(s)[819] Motion to file document under seal./ Progeria Research Foundation's Emergency Motion for Entry of an Order Authorizing Progeria Research Foundation to File Its Response Under Seal Filed by Interested Party Progeria Research Foundation (Attachments: # 1 Exhibit A - Proposed Order)) Responses due by 8/11/2025. (Okafor, M.)) No. of Notices: 1. Notice Date 08/03/2025. (Admin.)